Go Deep
Indo Us Bio-Tech Limited
Indo Us Bio-Tech Limited Score & Ratio Trend
Not enough history yet — this builds up over time as the company refreshes monthly. Check back in a few weeks.
Indo Us Bio-Tech Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 329,868,000.0 | 260,247,000.0 | 227,983,000.0 | 308,465,000.0 |
| Net Profit | 30,374,000.0 | 19,717,000.0 | 29,966,000.0 | 34,521,000.0 |
| EPS | 1.5 | 1.0 | 1.5 | 1.7 |
Indo Us Bio-Tech Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,104,391,254.0 | 1,038,384,012.0 | 728,362,968.0 | 617,447,518.0 | — |
| Net Profit | 131,229,141.0 | 162,674,252.0 | 82,405,520.0 | 72,403,580.0 | — |
| EPS | 6.5 | 8.1 | 4.1 | 3.8 | — |
Indo Us Bio-Tech Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,330,966,615.0 | 978,426,674.0 | 844,562,503.0 | 694,652,551.0 | — |
| Total Liabilities | 405,627,822.0 | 193,241,923.0 | 217,090,605.0 | 149,694,469.0 | — |
| Total Equity | 925,338,793.0 | 785,184,751.0 | 627,471,898.0 | 544,958,082.0 | — |
Indo Us Bio-Tech Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 4.6%Receivables 10.3%Inventory 75.1%Fixed assets (tangible) 8.8%Other assets 1.1%
How it's funded — Mar 2026
Short-term debt 27.1%Long-term debt 0.7%Other liabilities 2.3%Shareholders' equity 69.5%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 6.1 | 0.2 | 1.1 | 0.2 |
| Receivables | 13.8 | 15.0 | 19.0 | 24.7 |
| Inventory | 100.0 | 70.7 | 51.7 | 26.9 |
| Fixed assets (tangible) | 11.7 | 10.2 | 10.5 | 8.8 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1.5 | 1.7 | 2.1 | 8.8 |
| Liabilities & equity | ||||
| Short-term debt | 36.1 | 11.9 | 11.5 | 9.9 |
| Long-term debt | 1.0 | 2.9 | 2.8 | 1.7 |
| Payables | 0.4 | 1.1 | 4.4 | 1.8 |
| Other liabilities | 3.1 | 3.4 | 3.0 | 1.6 |
| Shareholders' equity | 92.5 | 78.5 | 62.7 | 54.5 |
| Net tangible assets | 92.5 | 78.5 | 62.7 | 54.5 |
Indo Us Bio-Tech Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -125,806,489.0 | 14,193,290.0 | 22,212,908.0 | 5,257,218.0 | — |
| Investing Activities | -15,000,562.0 | -7,924,369.0 | -25,275,133.0 | -66,739,470.0 | — |
| Financing Activities | 199,558,937.0 | -14,774,630.0 | 12,151,216.0 | 62,894,509.0 | — |